IFM Therapeutics
0 followers
At IFM Therapeutics, they work to improve the lives of patients with inflammatory disorders and cancer by developing transformative medicines that precisely target the innate immune system, the body’s first line of immunological response, and an essential component of immune function.
Org chart
H. Martin Seidel
Collapse
Dennis Dean
Chief Development Officer
Ed Olhava
SVP of Preclinical Development
Christopher M. Lindblom
VP, Finance
Ann Santilli
Executive Assistant Office Manager
Ayman F. El-Kattan
Executive Director-DMPK Lead
Eicke Latz
Scientific Co-founder and consultant
Shankar Venkatraman
Executive Director
Sujen Lai, PMP
Director
Chris Lindblom, CPA and MBA
Vice President of Finance and Treasurer
